GILEAD 701 (Truvada 200 mg / 300 mg)
Generic Name: emtricitabine/tenofovir
Pill imprint GILEAD 701 has been identified as Truvada 200 mg / 300 mg.
Truvada is used in the treatment of pre-exposure prophylaxis; hiv infection; nonoccupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 200 mg / 300 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 200 mg / 300 mg
- 19.00 mm
- Prescription only
FD&C Blue No. 2
|NDC Code||Manufacturer / Repackager|
|54569-5588||A-S Medication Solutions, LLC (repackager)|
|54868-5141||Physicians Total Care Inc (repackager)|
|55045-3481||Dispensing Solutions Inc. (repackager)|
|35356-0070||Lake Erie Medical and Surgical Supply (repackager)|
|52959-0969||H.J. Harkins Company, Inc (repackager)|
Note: Inactive ingredients may vary.
More about Truvada (emtricitabine / tenofovir)
- Other brands: AccessPak for HIV PEP Basic
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.